Amid worries in the American public that an unsafe vaccine could be approved by the US Food and Drug Administration just in time for the Nov. 3 election, the FDA...
OQ Chemicals – formerly Oxea – has agreed to license its proprietary technology for the production of ethylene and propylene derivatives to Oman’s Duqm Refinery and...
Clariant has announced it will build a new catalyst plant in China, its third in the country, as the Swiss group strives to strengthen its existing network.
Sanofi and GSK have agreed a deal with the EU to supply up to 300 million doses of their recombinant protein-based Covd-19 vaccine pending regulatory approval, which is...
German biotech BioNTech has signed a share purchase agreement with Novartis to acquire the Swiss drugmaker’s GMP-certified manufacturing facility in Marburg, Germany. The...
Mylan has agreed to buy the related intellectual property and commercialization rights of Aspen Pharmacare’s European thrombosis business for €641.9 million. The company...
Petronas Chemicals Group is to acquire 50% of Germany-based PCC’s share in PCC Oxyalkylates Malaysia, thereby entering the growing oxyalkylates market. The companies will...
After a roller coaster ride entailing months of on again-off again negotiations with US president Donald Trump over drug prices, the country’s pharmaceutical industry is...
Brazilian petrochemical group Braskem has started up a 450,000 t/y PP plant in LaPorte, Texas, USA. The facility, named Delta, produces a variety of grades, including...
